An oncolytic adenovirus expressing interleukin-24 enhances antitumor activities in combination with paclitaxel in breast cancer cells
Lin Fang(Anhui Medical University), Junnian Zheng(Jiangsu University)
Cited by 24
Related Papers
BRG1 Is a Prognostic Marker and Potential Therapeutic Target in Human Breast Cancer
|PLoS ONE|2013|103
Long-read sequencing reveals the landscape of aberrant alternative splicing and novel therapeutic target in colorectal cancer
|Genome Medicine|2023|44
Alcohol Drinking and Amyotrophic Lateral Sclerosis: An Instrumental Variable Causal Inference
|Annals of Neurology|2020|33